• Info
  • Insider Ownership

Insider Trading & Ownership of David Happel

Location
Novato, CA
Summary
The estimated net worth of David Happel is at least $6.3M dollars as of 23 Jul 2025. David Happel is the President & CEO, Director of Sagimet Biosciences Inc. and owns shares of Sagimet Biosciences Inc. (SGMT) stock worth about $6.3M.
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when David Happel files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of David Happel

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SGMT Sagimet Biosciences Inc. President & CEO, Director $6.3M -$598K -8.67% 21 Jul 2025

Insider Transactions Reported by David Happel:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.